is compounded semaglutide being banned "semaglutide" not FDA-approved Novo pressures GLP-1 compounders as
Description
Telehealth prescribing of GLP-1 medications is rapidly reshaping how diabetes and weight management care is delivered

As Healio previously reported, the FDA removed tirzepatide (Mounjaro/Zepbound, Eli Lilly) and semaglutide (Ozempic/Wegovy, Novo Nordisk) from its drug shortage list in 2024 and 2025, respectively, and now prohibits both 503A compounding pharmacies and 503B outsourcing facilities from distributing compounded versions of the drug
Patients using it benefit from standardized dosing and well-established protocols

As we witness a revolution in how we approach weight management and metabolic wellness, the intersection of these advanced treatments and gastrointestinal health has become a focal point of scientific curiosity and patient interest
Alhadeff AL, Hayes MR, Grill HJ (2014c)
You can book directly with our Grove City clinic
